Details of the Drug

General Information of Drug (ID: DMMTXKO)

Drug Name
(Z)-1-(pyridazin-3-yl)octadec-9-en-1-one
Synonyms CHEMBL405089; SCHEMBL3967504; BDBM50374371; (9z)-1-pyridazin-3-yloctadec-9-en-1-one
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 2 Molecular Weight (mw) 344.5
Logarithm of the Partition Coefficient (xlogp) 7.3
Rotatable Bond Count (rotbonds) 16
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C22H36N2O
IUPAC Name
(Z)-1-pyridazin-3-yloctadec-9-en-1-one
Canonical SMILES
CCCCCCCC/C=C\\CCCCCCCC(=O)C1=NN=CC=C1
InChI
InChI=1S/C22H36N2O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-22(25)21-18-17-20-23-24-21/h9-10,17-18,20H,2-8,11-16,19H2,1H3/b10-9-
InChIKey
REQRZXMTFPJHJQ-KTKRTIGZSA-N
Cross-matching ID
PubChem CID
12071714
TTD ID
D0A2SK

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid amide hydrolase (FAAH) TTDP1UC NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Fatty acid amide hydrolase (FAAH) DTT NO-GeName 2.65E-01 0.02 0.1
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95.